Canopy Growth (CGC) EBITDA Margin Growth (3y) (2022 - 2026)
Canopy Growth (CGC) EBITDA Margin Growth (3y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 1,129.00 |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 2.00 |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 59.00 |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | -1,031.00 |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | -925.00 |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | -46.00 |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 6,666.00 |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Canopy Growth | 449.71 Mn | 202.70 Mn | 16.08 Mn | 3,962.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3,962.00 |
| Dec 31, 2025 | 10,194.00 |
| Sep 30, 2025 | 14,429.00 |
| Jun 30, 2025 | 152,124.00 |
| Dec 31, 2024 | 6,487.00 |
| Sep 30, 2024 | 9,099.00 |
| Jun 30, 2024 | 9,385.00 |
| Mar 31, 2024 | 1,046.00 |
| Dec 31, 2023 | 310,870.00 |
| Sep 30, 2023 | 20,008.00 |
| Jun 30, 2023 | 7,308.00 |
| Mar 31, 2023 | 44,966.00 |
| Dec 31, 2022 | 2,263.00 |
| Sep 30, 2022 | 18,389.00 |
| Jun 30, 2022 | -131,529.00 |
| Mar 31, 2022 | 11,198.00 |